RESCUESKIN Laboratories Revenue and Competitors
Estimated Revenue & Valuation
- RESCUESKIN Laboratories's estimated annual revenue is currently $310k per year.
- RESCUESKIN Laboratories's estimated revenue per employee is $155,000
Employee Data
- RESCUESKIN Laboratories has 2 Employees.
- RESCUESKIN Laboratories grew their employee count by -60% last year.
RESCUESKIN Laboratories's People
Name | Title | Email/Phone |
---|
RESCUESKIN Laboratories Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is RESCUESKIN Laboratories?
The most advanced skincare product on the market today we are the only skincare science company that developed our core actives from Adult Human Stem Cells from bone marrow—recognized in the scientific community as the golden standard source for stem cells. We culture these stem cells, which are then filtered to collect active cellular components such as peptides, proteins, enzymes, cytokines, and exosomes that are all present when healthy skin cells grow. Our core formula contains these exclusive cellular actives. Every step, from the sourcing of the original cells to final formula production, is done at our research facility in Aliso Viejo, California. A truly American made product from beginning to the end. (Ok, maybe only some of our packaging are made in China but that's it.)
keywords:N/AN/A
Total Funding
2
Number of Employees
$310k
Revenue (est)
-60%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.1M | 2 | -71% | N/A |
#2 | $0.2M | 3 | -40% | N/A |
#3 | N/A | 3 | -25% | N/A |
#4 | $0.3M | 3 | N/A | N/A |
#5 | $0.3M | 4 | -33% | N/A |